source
- Sling Therapeutics raises $123M Series C to advance oral thyroid eye disease drugSling Therapeutics raised $123 million in a Series C financing round to move its oral drug candidate for thyroid eye disease forward. The capital will fund development of linsitinib, the only late…
- Senator Todd Young urges White House to appoint biotech leader amid rising Chinese innovationSenator Todd Young, chair of the National Security Commission on Emerging Biotechnology, told Fierce he is concerned about China’s expanding role in biopharma. The commission notes that Chinese co…